TRANSCEND CAPITAL ADVISORS, LLC Bristol-Myers Squibb Company Transaction History

TRANSCEND CAPITAL ADVISORS, LLC portfolio value:

$9.40M
portfolio value

TRANSCEND CAPITAL ADVISORS, LLC quarter portfolio value change:

-7.68%
quarter

Bristol-Myers Squibb Company 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +2.24% 2.89K shares -559K $71.09 132.25K
Q2 2022 share Decrease -0.20% -261 shares 495K $77 129.36K
Q1 2022 share Increase +1.05% 1.34K shares 1.46M $73.03 129.62K
Q4 2021 share Decrease -0.80% -1.03K shares 467K $62.52 128.27K
Q3 2021 share Decrease -20.03% -32.38K shares -3.26M $59.17 129.30K
Q2 2021 share Increase +0.57% 910 shares 654K $65.79 161.69K
Q1 2021 share Decrease -1.96% -3.21K shares -29K $62.15 160.78K
Q4 2020 share Decrease -14.07% -26.84K shares -1.33M $60.6 163.99K
Q3 2020 share Decrease -1.48% -2.86K shares 116K $58 190.84K
Q2 2020 share Decrease -4.08% -8.23K shares 134K $56.14 193.70K
Q1 2020 share Decrease -0.62% -1.26K shares -1.78M $52.79 201.94K
Q4 2019 share Increase 0.00% 203.21K shares 13.04M $60.36 203.21K